Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Fusidate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 653Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Request to take over the Fucidin marketing authorisation
    Request to take over the Fucidin marketing authorisation

    30 Mar 2020

    // CBG

    https://english.cbg-meb.nl/latest/news/2020/03/31/request-to-take-over-the-fucidin-marketing-authorisation

    CBG
    30 Mar 2020
    Share Share
    Arrevus Receives FDA Orphan Drug Designation for ARV-1801 (sodium fusidate)
    Arrevus Receives FDA Orphan Drug Designation for ARV-1801 (sodium fusidate)

    18 Feb 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200218005129/en

    BUSINESSWIRE
    18 Feb 2020
    Share Share
    Arrevus Receives FDA Qualified Infectious Disease Product (QIDP) Designation
    Arrevus Receives FDA Qualified Infectious Disease Product (QIDP) Designation

    29 Jan 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200128005542/en/Arrevus-Receives-FDA-Qualified-Infectious-Disease-Product/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    29 Jan 2020
    Share Share